SPINELLI SILVANO

CIK 00012745461 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001274546

Recent Transactions

24 trades

Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2005-02-28+125,000→ 125,000 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2005-02-28+125,000→ 125,000 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.83/sh−572→ 357,638 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.84/sh−2,550→ 358,210 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.79/sh−7,000→ 333,760 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.79/sh−7,000→ 333,760 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.78/sh−8,700→ 325,060 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.76/sh−4,300→ 320,760 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.80/sh−5,000→ 340,760 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.82/sh−11,878→ 345,760 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.84/sh−2,550→ 358,210 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.83/sh−572→ 357,638 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.82/sh−11,878→ 345,760 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.80/sh−5,000→ 340,760 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.78/sh−8,700→ 325,060 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-04$7.76/sh−4,300→ 320,760 total
Sale
CTI BIOPHARMA CORP
Common Stock
2004-01-05$10.37/sh−30,000→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2004-01-05$10.37/sh−30,000→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2004-01-05$9.64/sh−10,000→ 136,000 total
Sale
CTI BIOPHARMA CORP
Common Stock
2004-01-05$9.64/sh−10,000→ 136,000 total
Sale
CTI BIOPHARMA CORP
Common Stock
2004-01-02$9.57/sh−20,000→ 176,000 total
Sale
CTI BIOPHARMA CORP
Common Stock
2004-01-02$9.52/sh−20,000→ 176,000 total
Sale
CTI BIOPHARMA CORP
Common Stock
2004-01-02$9.52/sh−20,000→ 176,000 total
Sale
CTI BIOPHARMA CORP
Common Stock
2004-01-02$9.57/sh−20,000→ 176,000 total

Companies

CTI BIOPHARMA CORP
Director, EVP, Development

Recent Filings

Address

501 ELLIOTT AVE W. SUITE 400

SEATTLE, WA, 98119

View on SEC.gov